These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16515483)

  • 1. Effects of antiretroviral therapy on immunity in patients infected with HIV.
    Feola DJ; Thornton AC; Garvy BA
    Curr Pharm Des; 2006; 12(9):1015-22. PubMed ID: 16515483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
    Wagstaff AJ; Bryson HM
    Drugs; 1994 Aug; 48(2):199-226. PubMed ID: 7527325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacogenetics of antiretroviral therapy 2008: toward personalized treatment?].
    Vidal Marsal F
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 6():1-3. PubMed ID: 18680689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-based therapies: an adjunct to antiretroviral treatment.
    Jacobson JM
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):90-7. PubMed ID: 16091254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the virus-immune system interactions in the peripheral bloodstream of HIV infected individuals using a cellular automata model with considering the effects of antiretroviral therapy.
    Golpayegani GN; Jafari AH; Dabanloo NJ
    Technol Health Care; 2017; 25(1):59-88. PubMed ID: 27689554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiviral treatment regimens].
    Esser S
    Hautarzt; 2006 Nov; 57(11):961-2, 964-8. PubMed ID: 17053925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infections with human immunodeficiency viruses. Part II: Antiretroviral drugs, therapeutic options, and diagnostics].
    Stock I
    Med Monatsschr Pharm; 2011 Jul; 34(7):234-44; quiz 245-6. PubMed ID: 21809598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 2.
    Ruane PJ; Daar ES
    AIDS Read; 2004 Sep; 14(9):487-98. PubMed ID: 15457602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and renal disease: a contemporary review.
    Gameiro J; Jorge S; Lopes JA
    Int J STD AIDS; 2018 Jun; 29(7):714-719. PubMed ID: 29343165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy and management of HIV infection.
    Volberding PA; Deeks SG
    Lancet; 2010 Jul; 376(9734):49-62. PubMed ID: 20609987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in antiretroviral therapy in HIV infection.
    Arora DR; Gautam V; Gill PS; Mishra N
    J Indian Med Assoc; 2010 Jan; 108(1):29-34. PubMed ID: 20839577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy: a primer for dermatologists.
    Kim HN; Harrington RD
    Dermatol Clin; 2006 Oct; 24(4):537-47, vii. PubMed ID: 17010782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral drugs in HIV-infected children.
    Viganò A; Manfredini V; Penagini F; Giacomet V; Zuccotti GV
    Pharmacol Res; 2011 Jul; 64(1):1-3. PubMed ID: 21255650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 16. New drug targets for HIV.
    Bean P
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S96-100. PubMed ID: 16265623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of renal disease in children with HIV infection.
    Jindal AK; Tiewsoh K; Pilania RK
    Infect Dis (Lond); 2018 Jan; 50(1):1-12. PubMed ID: 28885079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transmission of antiretroviral drug resistant strains in patients diagnosed with human immunodeficiency virus infection in Gran Canaria in the period 2009-2012].
    Chamizo-López FJ; Gilarranz-Luengo R; Hernández-Febles M; Pena-López MJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):695-6. PubMed ID: 24666476
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of an empirical antiretroviral treatment depends on the primary resistance rate of the human immunodeficiency virus].
    Fernández Gutiérrez Del Álamo C; López Tinoco E; Fernández Rodríguez A; Soto Cárdenas MJ; Lozano Domínguez C; Bernal Martínez S; Guerrero Sánchez F; Girón-González JA
    Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):542-8. PubMed ID: 22365617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.